2019
DOI: 10.1080/1547691x.2019.1665597
|View full text |Cite
|
Sign up to set email alerts
|

Analyses of the toxic properties of recombinant human Cyclophilin A in mice

Abstract: Cyclophilin A (CypA), an 18 kDa multi-functional protein with cis-trans isomerase activity, is both a ligand for cyclosporine A and a proinflammatory factor. CypA is also a chemoattractant for hemopoietic stem cells and progenitors of different lineages, and can mediate regenerative processes in an organism. Accumulated experimental data have suggested there are practical applications for this protein in the treatment of several diseases (i.e. neutralization of cyclosporine A side effects, etc.). However, the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 38 publications
0
5
0
Order By: Relevance
“…High levels of CypA, similar to other pro-inflammatory cytokines, could impair placentation, leading to defects in fetal development and fetal death. This effect of CypA could be mediated by inducing the expression of serum amyloid alpha (SAA) [36]. SAA at significantly elevated concentrations inhibits trophoblast invasiveness [37] and contributes to early pregnancy loss [38].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…High levels of CypA, similar to other pro-inflammatory cytokines, could impair placentation, leading to defects in fetal development and fetal death. This effect of CypA could be mediated by inducing the expression of serum amyloid alpha (SAA) [36]. SAA at significantly elevated concentrations inhibits trophoblast invasiveness [37] and contributes to early pregnancy loss [38].…”
Section: Discussionmentioning
confidence: 99%
“…Recombinant human cyclophilin A (rhCypA), schemes of administration. RhCypA (E. coli) was produced as previously described [36,70]. F1(CBA/Lac × C57BL/6) female and male mice (18-22 g) were mated, and females were selected the next morning by a copulative plug (0.5 day post-coitus, dpc).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Due to the great range of eCyps levels reported in patients (among 7.8 pg/ml and 3 μg/ml) ( Mutlu et al, 2017 ; Zhang et al, 2017 ; Alfonso et al, 2019 ), eCyps concentrations (0.25 and 0.5 μg/ml) were chosen based on previous works with endothelial cells and eCypA ( Kim et al, 2004 ; Jin et al, 2004 ; Xue et al, 2017 ), taking into account that the selected doses had pathophysiological relevance. Moreover, Cyps are highly conserved proteins, human and mouse sequences have near-full homology, so effects of human Cyps on in vitro and in vivo rodent models provide valuable outcomes ( Wang and Heitman, 2005 ; Kalinina et al, 2019 ; Cao et al, 2020 ). In this context, human recombinant proteins were used in order to mimic the pathological conditions observed in inflammation-based illnesses such as diabetes, cardiovascular and metabolic diseases.…”
Section: Methodsmentioning
confidence: 99%
“…Indeed, CypA gene-deficient mice are protected from acetaminophen-induced liver toxicity and inflammation, leading to the description of CypA as a Damage-Associated Molecular Pattern [7]. Indeed, the administration of supraphysiologic doses of recombinant CypA to mice can induce systemic inflammation [8]. CD147, the only known CypA receptor, is also expressed by many non-leukocyte populations, including tubular epithelial cells of the kidney [1,9,10].…”
Section: Introductionmentioning
confidence: 99%